Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stites, S. W.
Right arrow Articles by Wesselius, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stites, S. W.
Right arrow Articles by Wesselius, L. J.
(Chest. 1995;107:1681-1685.)
© 1995 American College of Chest Physicians

Transferrin Concentrations in Serum and Lower Respiratory Tract Fluid of Mechanically Ventilated Patients With COPD or ARDS

Steven W. Stites MD1; Michael E. Nelson MD2; and Lewis J. Wesselius MD, FCCP2

1 From the Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Kansas School of Medicine, Kansas City, Kan
2 From the Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Kansas School of Medicine, Kansas City, Kan; From the Department of Medicine, Kansas City Department of Veteran Affairs Medical Center, Kansas City, Mo

Transferrin serves as the primary iron transport protein in serum, but it also is present in the lower respiratory tract where it has antioxidant and antibacterial properties. Prior studies indicate that patients with respiratory failure (RF) due to ARDS have increased concentrations of transferrin in the lower respiratory tract, which is attributed to increased lung vascular permeability. It is unclear whether mechanical ventilation contributes to increased lung transferrin content in patients with ARDS, although mechanical ventilation may increase lung microvascular permeability. To assess whether mechanical ventilation in patients with RF due to causes other than ARDS is also associated with increased respiratory tract concentrations of transferrin, we compared transferrin concentrations in serum and lung lavage fluid obtained from 12 mechanically ventilated patients with RF attributable to COPD, 6 patients with ARDS, and 15 healthy volunteers. Serum transferrin concentrations in patients with RF due to COPD were variable, but mean concentrations were similar to those in control subjects (336±58 vs 307±9 [SE] mg/dL), whereas serum transferrin concentrations were decreased in patients with ARDS (182±68 mg/dL; p<0.05). Compared with control subjects, lavage fluid recovered from patients with RF due to COPD contained significantly decreased concentrations of transferrin (1.56±0.24 vs 4.27±0.44 µg/mL; p<0.001), whereas transferrin concentrations in lavage fluid recovered from patients with ARDS were increased (15.72±2.01 µg/mL; p<0.001). Transferrin concentrations of lavage fluid also were decreased in COPD patients when normalized for lavage fluid protein content (4.35±0.72 vs 19.96±3.13 µg/mg in control subjects, p<0.001). These data indicate that mechanical ventilation of patients with COPD is associated with decreased lung transferrin concentrations, in contrast to an increased transferrin concentration found in patients with ARDS. Decreased transferrin concentrations in the lower respiratory tract may decrease defenses against oxidant injury and bacterial infection in patients with RF due to COPD.

Key Words: antioxidants • lung lavage • respiratory failure • transferrin

Submitted on April 4, 1994
Accepted on November 10, 2007




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. M. Smirnov, K. Bailey, C. H. Flowers, N. W. Garrigues, and L. J. Wesselius
Effects of TNF-alpha and IL-1beta on iron metabolism by A549 cells and influence on cytotoxicity
Am J Physiol Lung Cell Mol Physiol, August 1, 1999; 277(2): L257 - L263.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. E. Nelson, T. C. Wald, K. Bailey, and L. J. Wesselius
Intrapulmonary Cytokine Accumulation Following BAL and the Role of Endotoxin Contamination
Chest, January 1, 1999; 115(1): 151 - 157.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
F. Mateos, J. H Brock, and J. L. Pérez-Arellano
Iron metabolism in the lower respiratory tract
Thorax, July 1, 1998; 53(7): 594 - 600.
[Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. J. Ghio, J. D. Carter, J. H. Richards, L. E. Brighton, J. C. Lay, and R. B. Devlin
Disruption of normal iron homeostasis after bronchial instillation of an iron-containing particle
Am J Physiol Lung Cell Mol Physiol, March 1, 1998; 274(3): L396 - L403.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American College of Chest Physicians.